Results 221 to 230 of about 11,970 (271)
Effects of methylxanthine drugs on pyrogen-induced hyperthermia
The hyperthermic response to pyrogen was not potentiated by caffeine or theophylline administered i.p. into cats or rabbit. Injection of these drugs into the anterior hypothalamus or into the third cerebral ventricle in cats was also without effect on ...
M J Dascombe
exaly +3 more sources
In vitro pyrogen test for toxic or immunomodulatory drugs
Pyrogenic contaminations of some classes of injectable drugs, e.g. toxic or immunomodulatory as well as false-positive drugs, represent a major risk which cannot yet be excluded due to the limitations of current tests.
Mardas Daneshian +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annals of the New York Academy of Sciences, 1998
ABSTRACT: In humans or experimental animals, the repeated confrontation with lipopolysaccarides (LPS) from gram‐negative bacteria, but not with muramyl dipeptide (MDP) from gram‐positive bacteria, leads to attenuation of almost all pathophysiologic effects mediated by proinflammatory cytokines.
Eugen, Zeisberger, Joachim, Roth
openaire +2 more sources
ABSTRACT: In humans or experimental animals, the repeated confrontation with lipopolysaccarides (LPS) from gram‐negative bacteria, but not with muramyl dipeptide (MDP) from gram‐positive bacteria, leads to attenuation of almost all pathophysiologic effects mediated by proinflammatory cytokines.
Eugen, Zeisberger, Joachim, Roth
openaire +2 more sources
Nature, 1968
Wyllie, Limbosch and Nyhus1, in commenting on the results of Baume, Nicholls and Baxter2, state that the inhibition of gastric secretion by lipopolysaccharide “was clearly described in 1950” by Blickenstaff and Grossman3. Blickenstaff and Grossman used ‘Pyromen’, a commercially available pyrogen (Nesset et al.4), which is very impure and only partially
openaire +2 more sources
Wyllie, Limbosch and Nyhus1, in commenting on the results of Baume, Nicholls and Baxter2, state that the inhibition of gastric secretion by lipopolysaccharide “was clearly described in 1950” by Blickenstaff and Grossman3. Blickenstaff and Grossman used ‘Pyromen’, a commercially available pyrogen (Nesset et al.4), which is very impure and only partially
openaire +2 more sources
Annals of the Rheumatic Diseases, 2023
No abstract ...
Angeli, Eurydice +5 more
openaire +3 more sources
No abstract ...
Angeli, Eurydice +5 more
openaire +3 more sources
Transactions of the New York Academy of Sciences, 1952
P A, ZAHL, S H, HUTNER
openaire +2 more sources
P A, ZAHL, S H, HUTNER
openaire +2 more sources
Development and validation of a novel luciferase reporter gene assay to detect pyrogen
Biologicals, 2022Mingren Wang, Lizhen Liu
exaly

